NTV Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$884K Hold
5,784
0.1% 157
2025
Q4
$797K Hold
5,784
0.08% 161
2025
Q3
$742K Sell
5,784
-287
-5% -$35K 0.08% 166
2025
Q2
$735K Sell
6,071
-150
-2% -$16.9K 0.09% 161
2025
Q1
$694K Hold
6,221
0.09% 157
2024
Q4
$605K Hold
6,221
0.08% 161
2024
Q3
$716K Hold
6,221
0.1% 147
2024
Q2
$662K Buy
6,221
+300
+5% +$30.1K 0.09% 146
2024
Q1
$573K Sell
5,921
-550
-8% -$56.4K 0.09% 153
2023
Q4
$653K Hold
6,471
0.11% 135
2023
Q3
$659K Sell
6,471
-22
-0.3% -$2.23K 0.12% 134
2023
Q2
$655K Sell
6,493
-310
-5% -$31K 0.11% 135
2023
Q1
$626K Buy
6,803
+400
+6% +$34.9K 0.12% 132
2022
Q4
$581K Sell
6,403
-100
-2% -$8.42K 0.11% 136
2022
Q3
$494K Sell
6,503
-223
-3% -$18.5K 0.1% 138
2022
Q2
$569K Hold
6,726
0.11% 138
2022
Q1
$590K Buy
6,726
+23
+0.3% +$1.99K 0.1% 147
2021
Q4
$586K Sell
6,703
-938
-12% -$77.9K 0.1% 150
2021
Q3
$625K Buy
7,641
+558
+8% +$50.2K 0.11% 143
2021
Q2
$646K Hold
7,083
0.11% 139
2021
Q1
$605K Buy
7,083
+100
+1% +$8.97K 0.11% 138
2020
Q4
$659K Hold
6,983
0.13% 121
2020
Q3
$607K Hold
6,983
0.14% 112
2020
Q2
$610K Hold
6,983
0.16% 111
2020
Q1
$576K Hold
6,983
0.19% 105
2019
Q4
$661K Buy
6,983
+238
+4% +$21.4K 0.17% 108
2019
Q3
$586K Buy
6,745
+100
+2% +$8.98K 0.17% 110
2019
Q2
$607K Sell
6,645
-771
-10% -$65.3K 0.17% 107
2019
Q1
$639K Sell
7,416
-335
-4% -$26.9K 0.18% 110
2018
Q4
$596K Hold
7,751
0.19% 108
2018
Q3
$598K Sell
7,751
-111
-1% -$8.21K 0.16% 122
2018
Q2
$532K Hold
7,862
0.15% 127
2018
Q1
$570K Sell
7,862
-223
-3% -$17K 0.16% 124
2017
Q4
$608K Sell
8,085
-128
-2% -$9.66K 0.17% 118
2017
Q3
$632K Sell
8,213
-375
-4% -$28.3K 0.18% 114
2017
Q2
$642K Sell
8,588
-223
-3% -$15.8K 0.2% 111
2017
Q1
$586K Hold
8,811
0.19% 112
2016
Q4
$575K Sell
8,811
-223
-2% -$14.5K 0.2% 109
2016
Q3
$639K Hold
9,034
0.23% 101
2016
Q2
$667K Sell
9,034
-279
-3% -$19.3K 0.25% 98
2016
Q1
$604K Sell
9,313
-2,678
-22% -$182K 0.23% 104
2015
Q4
$924K Sell
11,991
-224
-2% -$17.8K 0.36% 82
2015
Q3
$1.01M Sell
12,215
-334
-3% -$29.7K 0.33% 90
2015
Q2
$1.1M Hold
12,549
0.32% 97
2015
Q1
$1.11M Hold
12,549
0.33% 94
2014
Q4
$1.04M Buy
12,549
+223
+2% +$18.5K 0.31% 97
2014
Q3
$1.04M Hold
12,326
0.32% 91
2014
Q2
$999K Hold
12,326
0.3% 96
2014
Q1
$939K Hold
12,326
0.3% 94
2013
Q4
$887K Buy
12,326
+78
+0.6% +$5.42K 0.3% 93
2013
Q3
$841K Hold
12,248
0.29% 96
2013
Q2
$776K Buy
+12,248
New +$797K 0.28% 97

Other funds holding NVS

NTV Asset Management's NVS Position: Q1 2026 in Review

NTV Asset Management held its Novartis (NVS) position steady in Q1 2026 at 5,784 shares worth $884K. The position accounts for 0.1% of the portfolio, ranked #157.

NTV Asset Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.11M in Q1 2015. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • NTV Asset Management held 5,784 shares of Novartis worth $884K as of Q1 2026.
  • NTV Asset Management left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.1% of NTV Asset Management's portfolio in Q1 2026, its #157 holding.
  • NTV Asset Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • NTV Asset Management's Novartis position peaked at $1.11M in Q1 2015.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.